National Cancer Centre Singapore at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
National Cancer Centre Singapore takes part in 8 sessions at ESMO 2026 in Madrid. Its program centres on immunotherapy and antibody-drug conjugates, including cancer vaccines and conjugates for triple-negative breast cancer and HER2-altered non-small cell lung cancer. Other sessions cover nasopharyngeal carcinoma, anal squamous cell carcinoma, neuroendocrine prostate cancer and treatment around surgery for gene-driven early lung cancer.
| Organization | ESMO 2026 Attendance |
|---|---|
National Cancer Centre Singapore Singapore, Singapore | |
Public specialist cancer centre in Singapore, part of the SingHealth public healthcare cluster. | Satellite Fri Oct 23 10:40–11:05 Chair Sat Oct 24 08:30–10:00 Abstract Sat Oct 24 08:45–09:00 Chair Sun Oct 25 08:30–10:00 Chair Sun Oct 25 10:15–11:30 Evolving treatment paradigms in nasopharyngeal carcinoma Sarcoma, CNS, head & neck and rare cancers Talk Sun Oct 25 10:40–11:00 The role of radiation oncologist Sarcoma, CNS, head & neck and rare cancers Chair Mon Oct 26 08:30–09:15 Anal squamous cell carcinoma: State of the art and future perspectives Gastrointestinal cancers Chair Mon Oct 26 10:15–11:00 Challenges in the management of neuro-endocrine and small cell prostate cancer Genitourinary cancers Talk Mon Oct 26 17:10–17:30 Peri-operative strategies in oncogene driven resectable early stage NSCLC Lung & thoracic cancers Satellite Mon Oct 26 19:20–19:40 Satellite Mon Oct 26 19:40–20:00 |
Instantly find 20 buyers from National Cancer Centre Singapore
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction